Agios Pharmaceuticals
ISIN US00847X1046
|WKN A1W2RM
| Invest in ETFs without Lightyear execution fees. | Capital at risk. Other fees and T&C apply. Overview
Description
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States
Chart
Financials
Key metrics
| Market capitalisation, EUR | 1,846.80 m |
| EPS, EUR | 10.49 |
| P/B ratio | 1.19 |
| P/E ratio | 2.99 |
| Dividend yield | 0.00% |
Income statement (2023)
| Revenue, EUR | 24.81 m |
| Net income, EUR | -325.68 m |
| Profit margin | -1,312.63% |
What ETF is Agios Pharmaceuticals in?
There are 28 ETFs which contain Agios Pharmaceuticals. All of these ETFs are listed in the table below. The ETF with the largest weighting of Agios Pharmaceuticals is the L&G Pharma Breakthrough UCITS ETF.
| ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
|---|---|---|---|---|---|---|---|---|
| JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (acc) | 0.03% | Equity United States Small Cap | 1,374 | 0.14% | 60 | +25.62% | A3DQ08 | IE000JNKVS10 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (hedged to EUR) A-acc | 0.00% | Equity United States Multi-Factor Strategy | 1,919 | 0.28% | 7 | +18.47% | A2DWAC | IE00BDGV0746 |
| L&G Russell 2000 US Small Cap Quality UCITS ETF | 0.11% | Equity United States Small Cap | 1,021 | 0.30% | 228 | +22.71% | A0Q8H2 | IE00B3CNHJ55 |
| WisdomTree BioRevolution UCITS ETF USD Acc | 1.87% | Equity World Health Care Social/Environmental Biotech | 88 | 0.45% | 4 | -1.76% | A3CY21 | IE000O8KMPM1 |
| JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) | 0.03% | Equity United States Small Cap | 1,374 | 0.14% | 177 | +26.06% | A3DQ09 | IE0001O84583 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (USD) A-dis | 0.00% | Equity United States Multi-Factor Strategy | 1,919 | 0.25% | 34 | +25.56% | A2DND0 | IE00BDGV0308 |
| L&G Global Thematic ESG Exclusions UCITS ETF USD Accumulating | 0.38% | Equity World Social/Environmental Innovation | 366 | 0.60% | 4 | +17.53% | A3DHPA | IE000VTOHNZ0 |
| iShares MSCI World Small Cap UCITS ETF | 0.02% | Equity World Small Cap | 3,316 | 0.35% | 4,929 | +20.32% | A2DWBY | IE00BF4RFH31 |
| Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C | 0.05% | Equity World Health Care Social/Environmental | 115 | 0.35% | 82 | +10.64% | DBX0SM | IE00036F4K40 |
| Vanguard ESG North America All Cap UCITS ETF (USD) Accumulating | 0.01% | Equity North America Social/Environmental | 1,494 | 0.12% | 268 | +28.81% | A3DJRE | IE000O58J820 |
| SPDR Russell 2000 US Small Cap UCITS ETF | 0.07% | Equity United States Small Cap | 1,784 | 0.30% | 4,926 | +23.12% | A1XFN1 | IE00BJ38QD84 |
| Xtrackers MSCI Global SDGs Social Fairness Contributors UCITS ETF 1C | 0.01% | Equity World Social/Environmental | 226 | 0.35% | 3 | - | DBX0UT | IE000L2IS494 |
| WisdomTree Megatrends UCITS ETF USD | 0.09% | Equity World Social/Environmental Innovation | 643 | 0.50% | 18 | +23.15% | A3EYCN | IE0000902GT6 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (USD) A-acc | 0.00% | Equity United States Multi-Factor Strategy | 1,919 | 0.25% | 87 | +25.54% | A2JSD1 | IE00BDGV0415 |
| SPDR MSCI World Small Cap UCITS ETF | 0.02% | Equity World Small Cap | 3,544 | 0.45% | 952 | +19.86% | A1W56P | IE00BCBJG560 |
| iShares Ageing Population UCITS ETF | 0.21% | Equity World Health Care Social/Environmental Ageing Population | 341 | 0.40% | 373 | +21.87% | A2ANH1 | IE00BYZK4669 |
| Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.01% | Equity World Social/Environmental | 5,826 | 0.24% | 426 | +24.61% | A2QL8V | IE00BNG8L385 |
| Xtrackers Russell 2000 UCITS ETF 1C | 0.07% | Equity United States Small Cap | 1,498 | 0.30% | 2,183 | +22.94% | A1XEJT | IE00BJZ2DD79 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (hedged to CHF) A-acc | 0.00% | Equity United States Multi-Factor Strategy | 1,919 | 0.28% | 25 | +14.78% | A2DWAB | IE00BDGV0C91 |
| Xtrackers MSCI Global SDGs UCITS ETF 1C | 0.03% | Equity World Social/Environmental | 227 | 0.35% | 10 | +6.82% | DBX0SL | IE000PSF3A70 |
| iShares MSCI USA Small Cap ESG Enhanced UCITS ETF (Acc) | 0.01% | Equity United States Small Cap | 1,598 | 0.43% | 2,395 | +22.54% | A0X8SB | IE00B3VWM098 |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.19% | Equity United States Health Care Biotech | 265 | 0.35% | 31 | +9.21% | A2JDYM | IE00BDZVHG35 |
| iShares Nasdaq US Biotechnology UCITS ETF | 0.19% | Equity United States Health Care Biotech | 265 | 0.35% | 461 | +8.58% | A2DWAW | IE00BYXG2H39 |
| SPDR MSCI USA Small Cap Value Weighted UCITS ETF | 0.00% | Equity United States Small Cap | 1,731 | 0.30% | 590 | +22.76% | A12HU5 | IE00BSPLC413 |
| iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc) | 0.01% | Equity World Small Cap | 2,528 | 0.35% | 61 | +19.39% | A3C14G | IE000T9EOCL3 |
| Vanguard ESG North America All Cap UCITS ETF (USD) Distributing | 0.01% | Equity North America Social/Environmental | 1,494 | 0.12% | 30 | +29.23% | A3DJRF | IE000L2ZNB07 |
| Vanguard ESG Global All Cap UCITS ETF (USD) Accumulating | 0.01% | Equity World Social/Environmental | 5,826 | 0.24% | 489 | +24.71% | A2QL8U | IE00BNG8L278 |
| L&G Pharma Breakthrough UCITS ETF | 2.20% | Equity World Health Care Innovation | 37 | 0.49% | 18 | +12.44% | A2H9XR | IE00BF0H7608 |
Performance
Returns overview
| YTD | +3.15% |
| 1 month | +4.82% |
| 3 months | -21.21% |
| 6 months | -20.82% |
| 1 year | +48.88% |
| 3 years | +27.52% |
| 5 years | -28.98% |
| Since inception (MAX) | -28.16% |
| 2024 | +46.58% |
| 2023 | -20.78% |
| 2022 | -9.01% |
| 2021 | -23.60% |
Monthly returns in a heat map
Risk
Risk metrics in this section:
- Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
- Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
- Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
Risk overview
| Volatility 1 year | 58.56% |
| Volatility 3 years | 54.34% |
| Volatility 5 years | 52.65% |
| Return per risk 1 year | 0.83 |
| Return per risk 3 years | 0.16 |
| Return per risk 5 years | -0.13 |
| Maximum drawdown 1 year | -46.59% |
| Maximum drawdown 3 years | -46.59% |
| Maximum drawdown 5 years | -69.15% |
| Maximum drawdown since inception | -69.15% |
Rolling 1 year volatility
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.